Malaria and other infections induce polyreactive antibodies that impact SARS‐CoV‐2 seropositivity estimations in endemic settings
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29713 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Ruth Aguilar und 26 weiteren Autor:innen. Beteiligte Einrichtung: ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Catalonia, Spain. Hauptthemen laut MEDLINE: COVID-19, Antibodies, Viral, SARS-CoV-2, Immunoglobulin G. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Union under grant agreement no. 101046314 (END-VOC), Fundació Privada Daniel Bravo Andreu, Swedish government.
Abstract (Originalsprache)
Anti‐severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) seroprevalence is used to estimate the proportion of individuals within a population previously infected, to track viral transmission, and to monitor naturally and vaccine‐induced immune protection. However, in sub‐Saharan African settings, antibodies induced by higher exposure to pathogens may increase unspecific seroreactivity to SARS‐CoV‐2 antigens, resulting in false positive responses. To investigate the level and type of unspecific seroreactivitiy to SARS‐CoV‐2 in Africa, we measured immunoglobulin G (IgG), IgA, and IgM to a broad panel of antigens from different pathogens by Luminex in 602 plasma samples from African and European subjects differing in coronavirus disease 2019, malaria, and other exposures. Seroreactivity to SARS‐CoV‐2 antigens was higher in prepandemic African than in European samples and positively correlated with antibodies against human coronaviruses, helminths, protozoa, and especially Plasmodium falciparum . African subjects presented higher levels of autoantibodies, a surrogate of polyreactivity, which correlated with P. falciparum and SARS‐CoV‐2 antibodies. Finally, we found an improved sensitivity in the IgG assay in African samples when using urea as a chaotropic agent. In conclusion, our data suggest that polyreactive antibodies induced mostly by malaria are important mediators of the unspecific anti‐SARS‐CoV‐2 responses, and that the use of dissociating agents in immunoassays could be useful for more accurate estimates of SARS‐CoV‐2 seroprevalence in African settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Catalonia, Spain.
- CIBER de Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain.
- Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana.
- Department of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
- Komfo Anokye Teaching Hospital, Kumasi, Ghana.
- Clinical Immunology Unit, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
ORCID-Profile: Anthony A-A Awuah, Carlota Dobaño, Gemma Moncunill
Förderung
- European Union under grant agreement no. 101046314 (END-VOC)
- Fundació Privada Daniel Bravo Andreu
- Swedish government
- European and Developing Countries Clinical Trials Partnership
- The Global Health Agency Unitaid as part of ACT-A
- German Federal Ministry of Education and Research (BMBF) through KfW
- L.I. was supported by the PID2019-110810RB-I00 and PID2022-137031OB-I00 grants from the Spanish Ministry of Science & Innovation
- G.M. is supported by RYC 2020-029886-I/AEI/10.13039/501100011033, co- funded by European Social Fund (ESF)
Zitieren
APA
Aguilar, R., Jiménez, A., Santano, R., Vidal, M., Maiga-Ascofare, O., Strauss, R., Bonney, J., Agbogbatey, M., Goovaerts, O., Boham, E. E. A., Adu, E. A., Cuamba, I., Ramírez-Morros, A., Dutta, S., Angov, E., Zhan, B., Izquierdo, L., Santamaria, P., Mayor, A., …, & Moncunill, G. (2024). Malaria and other infections induce polyreactive antibodies that impact SARS‐CoV‐2 seropositivity estimations in endemic settings. Journal of Medical Virology. https://doi.org/10.1002/jmv.29713
Vancouver
Aguilar R, Jiménez A, Santano R, Vidal M, Maiga-Ascofare O, Strauss R, et al. Malaria and other infections induce polyreactive antibodies that impact SARS‐CoV‐2 seropositivity estimations in endemic settings. Journal of Medical Virology. 2024. doi:10.1002/jmv.29713
BibTeX
@article{Aguilar2024,
author = {Aguilar, Ruth and Jiménez, Alfons and Santano, Rebeca and Vidal, Marta and Maiga-Ascofare, Oumou and Strauss, Ricardo and Bonney, Joseph and Agbogbatey, Melvin and Goovaerts, Odin and Boham, Eric E A and Adu, Evan A and Cuamba, Inocencia and Ramírez-Morros, Anna and Dutta, Sheetij and Angov, Evelina and Zhan, Bin and Izquierdo, Luis and Santamaria, Pere and Mayor, Alfredo and Gascón, Joaquim and Ruiz-Comellas, Anna and Molinos-Albert, Luis M and Amuasi, John H and Awuah, Anthony A-A and Adriaensen, Wim and Dobaño, Carlota and Moncunill, Gemma},
title = {Malaria and other infections induce polyreactive antibodies that impact SARS‐CoV‐2 seropositivity estimations in endemic settings},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29713}
}
EUVIMED